Rare diseases
Investigational molecules
Locations
17. Listopadu 1790/5, Poruba, 708 00 Ostrava, Czechia
Clinical research in relapsing-remitting multiple sclerosis and primary progressive multiple sclerosis with interest in ocrelizumab therapeutic monitoring and the relationship between serum drug concentrations and clinical markers.
The research activity in this area centers on treatment individualization in neuroimmunology and the optimization of disease-modifying therapy.
Fakultni Nemocnice Ostrava runs clinical trials in conditions such as Multiple sclerosis, Heart failure with reduced ejection fraction, Lung assist device therapy, Femoral neck fracture, among others.
Clinical trials run by this sponsor – those enrolling participants first.
CzechiaCzechiaCzechiaCzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
